Immune mechanisms during preterm sepsis

Recruiting

• Conditions: blood-poisoning; sepsis; 10004018; 10028920

• Registration Number: NL-OMON49081
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Preterm and term newborns with a gestational age of 24 weeks to 42 weeks of
gestation who are admitted at the Erasmus Medical Centre-Sophia Children*s
Hospital

Exclusion Criteria

Parents that do not have sufficient understanding of the Dutch language and are
therefore not able to comprehend the patient information sheet

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To characterize the in vitro immune response of preterm and term newborns<br /><br>against sepsis-related bacteria during the first ten weeks after birth</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To compare the in vitro immune response of umbilical cord blood with the immune<br /><br>response of preterm and term newborns in the first months of life</p><br>